PNC Financial Services Group’s Juniper Pharmaceuticals, Inc. Common Stock JNP Stock Holding History

PNC Financial Services Group’s Portfolio JNP Stock Details JNP Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2018 Q3	–	Sell	-2,500	Closed	-$22K	–	4353
2018 Q2	$22K	Buy	+2,500	New	+$22.5K	﹤0.01%	3417

PNC Financial Services Group's JNP Position: Q3 2018 in Review

PNC Financial Services Group sold out of Juniper Pharmaceuticals, Inc. Common Stock (JNP) in Q3 2018, closing a stake of 2,500 shares — an estimated $22K sold.

PNC Financial Services Group first reported a position in JNP in Q2 2018 and held it in 1 quarter. The position peaked at $22K in Q2 2018. 0 funds tracked by Wall St. Rank hold JNP as of Q3 2018.

PNC Financial Services Group reported no remaining Juniper Pharmaceuticals, Inc. Common Stock position as of Q3 2018 after selling out during the quarter.
PNC Financial Services Group sold 2,500 Juniper Pharmaceuticals, Inc. Common Stock shares in Q3 2018, an estimated $22K.
PNC Financial Services Group first reported a position in Juniper Pharmaceuticals, Inc. Common Stock in Q2 2018 and held it in 1 quarter.
PNC Financial Services Group's Juniper Pharmaceuticals, Inc. Common Stock position peaked at $22K in Q2 2018.
0 funds tracked by Wall St. Rank held Juniper Pharmaceuticals, Inc. Common Stock as of Q3 2018.

Based on PNC Financial Services Group's 13F filing for Q3 2018, filed 9 Nov 2018.